A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 5,724 shares of JNJ stock, worth $888,193. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,724
Previous 4,812 18.95%
Holding current value
$888,193
Previous $703 Million 31.89%
% of portfolio
0.08%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $132,677 - $152,650
912 Added 18.95%
5,724 $928 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $33,207 - $36,289
230 Added 5.02%
4,812 $703 Million
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $3,880 - $4,068
25 Added 0.55%
4,582 $725 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $663,499 - $724,016
4,557 New
4,557 $714 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.